ADC Therapeutics America
UEI: Y9MBZX2C5RU5
• CAGE: 8WNM0
Overview
Parent Awardee
Name
ADC Therapeutics America
Headquarters
New Providence, NJ
United States
United States
Federal recipient
ADC THERAPEUTICS AMERICA, INC.
(UEI Y9MBZX2C5RU5, CAGE 8WNM0)
is headquartered in New Providence NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in June 2011 and
federally registered in
February 2021.
Federal Registration and Certifications
Legal Name
ADC THERAPEUTICS AMERICA, INC.
UEI
Y9MBZX2C5RU5
CAGE Code
8WNM0
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 6, 2011
Initial Registration
Feb. 2, 2021
Last Registration
July 28, 2025
Registration Activation
July 25, 2025
Registration Expiration
July 25, 2026
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at ADC Therapeutics America
GSA Schedules and Price Lists
- ADC Therapeutics America
- PoP: 9/30/21 - 9/30/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- ADC Therapeutics America
- PoP: 6/17/21 - 10/14/21 (Ended)